The role of induction therapy
- PMID: 24876935
- PMCID: PMC4037412
- DOI: 10.3978/j.issn.2072-1439.2014.03.10
The role of induction therapy
Abstract
The incidence of esophageal cancer has been steadily increasing. The 5-year survival of esophageal cancer has minimally improved over the past 30 years. In this article, we review the management of esophageal cancer, focusing on the literature investigating the role of induction chemotherapy and radiation therapy.
Keywords: Esophageal cancer; chemotherapy; radiation therapy; trimodality therapy.
References
-
- Siegel R, Naishadham D, Jemal A.Cancer statistics, 2012. CA Cancer J Clin 2012;62:10-29 - PubMed
-
- Ando N, Iizuka T, Ide H, et al. Surgery plus chemotherapy compared with surgery alone for localized squamous cell carcinoma of the thoracic esophagus: a Japan Clinical Oncology Group Study--JCOG9204. J Clin Oncol 2003;21:4592-6 - PubMed
-
- Ando N, Kato H, Igaki H, et al. A randomized trial comparing postoperative adjuvant chemotherapy with cisplatin and 5-fluorouracil versus preoperative chemotherapy for localized advanced squamous cell carcinoma of the thoracic esophagus (JCOG9907). Ann Surg Oncol 2012;19:68-74 - PubMed
-
- Zuccaro G, Jr, Rice TW, Vargo JJ, et al. Endoscopic ultrasound errors in esophageal cancer. Am J Gastroenterol 2005;100:601-6 - PubMed
Publication types
LinkOut - more resources
Full Text Sources
Miscellaneous